PHOENIX – A House panel voted Monday to extend the deadline on Arizona’s first-in-the-nation program to research medical uses of psilocybin, or “magic mushrooms,” a hallucinogenic currently classified ...
Canada has seen a 50% decline in Indian study permit approvals in 2025, with projections suggesting a 67.5% drop from 2023.
Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of bloodstream infections in adults undergoing allogeneic hematopoietic stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback